The Methodist Hospital Family Medicine Residency Program at the University of Minnesota in St. Louis Park, Minnesota, ...

Attention-deficit/hyperactivity disorder (ADHD) is underdiagnosed in girls and women, research shows. The reasons are ...

The study published in The Journal of Clinical Psychiatry examined 483 people with ADHD for 16 years — from the time they ...

Brilaroxazine hydrochloride is under clinical development by Reviva Pharmaceuticals and currently in Phase I for Major Depressive Disorder.

The increased pressure on children to meet ever-increasing standards and an intensely competitive environment is adding to ...

A University of Missouri study looks at unmedicated youths who have ADHD, or attention deficit hyperactivity disorder. The ...

From drug shortages to the approval of a nasal spray flu vaccine, the top population health stories explored critical ...

NLS Pharmaceutics Ltd. (NASDAQ:NLSP – Get Free Report) was the recipient of a large increase in short interest during the month of December. As of December 15th, there was short interest totalling 132 ...

Testing also found several brands of cinnamon with low lead levels that are safer to use in your holiday drinks. The bottom ...

Mazindol ER is under clinical development by NLS Pharmaceutics and currently in Phase II for Narcolepsy. According to GlobalData, Phase II drugs for Narcolepsy have a 59% phase transition success rate ...

Attention deficit hyperactivity disorder: pharmacological and psychological interventions in children, young people and adults.2008. London: The British Psychological Society and the Royal College ...